Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients-Reference-Cited by-同舟云学术

Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients

Published:2017-01-21 Issue: Volume: Page:ehw627
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Palmerini Tullio,Della Riva Diego,Benedetto Umberto,Bacchi Reggiani Letizia,Feres Fausto,Abizaid Alexandre,Gilard Martine,Morice Marie-Claude,Valgimigli Marco,Hong Myeong-Ki,Kim Byeong-Keuk,Jang Yangsoo,Kim Hyo-Soo,Park Kyung Woo,Colombo Antonio,Chieffo Alaide,Sangiorgi Diego,Biondi-Zoccai Giuseppe,Généreux Philippe,Angelini Gianni D.,Pufulete Maria,White Jonathon,Bhatt Deepak L.,Stone Gregg W.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/38/14/1034/11204253/ehw627.pdf

Reference26 articles.

1. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence

2. The Risk of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Bare-Metal and Drug-Eluting Stents

3. Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data

4. Royston P Lambert P. Flexible Parametric Survival Analysis Using STATA: Beyond the Cox Model. College Station, Texas: STATA PRESS; 2011.

5. Klein J Moeschberger M , Survival Analysis. Techniques for censored and truncated data. 2nd ed. New York: Springer Publishers; 2003.

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2Y12 Receptor Inhibitor for Antiaggregant Therapies: From Molecular Pathway to Clinical Application;International Journal of Molecular Sciences;2024-07-10

2. One-Month Dual Antiplatelet Therapy Followed by P2Y<sub>12</sub> Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation　― The REIWA Region-Wide Registry ―;Circulation Journal;2024-05-24

3. Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention;JAMA Cardiology;2024-05-01

4. One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes;EuroIntervention;2024-05

5. Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention;Circulation: Cardiovascular Interventions;2024-04